OXFORD, England, July 5, 2023 /PRNewswire/ — Ultromics, a leading health technology company advancing a novel approach for detecting heart failure and its phenotypes, announced today the assignment of a new outpatient code by the Centers for Medicare and Medicaid Services (CMS), for its flagship product, EchoGo® Heart Failure. CMS established a new […]
Other News
FUJIFILM Sonosite Introduces the All-Touchscreen Sonosite ST POCUS System, Designed and Engineered to Support Procedural Workflows
BOTHELL, Wash., July 03, 2023 (GLOBE NEWSWIRE) — FUJIFILM Sonosite, Inc. – The world leader in point-of-care ultrasound (POCUS) solutions has added to its leading portfolio of systems with the launch of the Sonosite ST. Designed with the busy proceduralist in mind, Sonosite ST offers a new 21-inch all-touchscreen interface, a large […]
BioCardia Completes Submission of CardiAMP Cell Therapy System in Heart Failure to Japan’s Pharmaceutical Medical Device Agency
SUNNYVALE, Calif. , July 05, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces it completed its submission of the CardiAMP Cell Therapy System to Japan’s Pharmaceutical and Medical Device Agency (PMDA) towards approval for the […]
AtriCure to Announce Second Quarter 2023 Financial Results
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that it will release second quarter 2023 financial results on Tuesday, July 25, 2023. AtriCure will host an audio webcast at 4:30 […]
FEops Receives FDA Clearance for Its AI-Based Anatomical Analysis Capabilities
Enabling a time-efficient workflow and better-informed clinical decision making for structural heart interventions GENT, Belgium–(BUSINESS WIRE)–FEops announced today its new release of FEops HEARTguide™, including an AI-based anatomical analysis of MSCT images for the pre-operative planning of structural heart interventions. With this introduction, physicians don’t need to do the measurements […]
Bioheart (02185.HK) announces clinical result for Iberis-HTN at CIT 2023
SHANGHAI, June 29, 2023 /PRNewswire/ — Bioheart (02185.HK), together with its holding subsidiary Angiocare announces the clinical result for Iberis-HTN at China Interventional Therapeutics 2023. Iberis-HTN is a prospective, multicenter, blinded, randomized controlled trial to evaluate the safety and efficacy of the Iberis® Multi-Electrode Renal Artery Radiofrequency Ablation Catheter System for the treatment […]
Ardelyx, Inc. Reports Employment Inducement Grants
WALTHAM, Mass., June 29, 2023 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that on June 28, 2023, the compensation committee of the company’s board of directors granted four new […]
Alnylam Announces Date of Planned FDA Advisory Committee Meeting for ONPATTRO® (patisiran) for the Treatment of the Cardiomyopathy of ATTR Amyloidosis
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced that the U.S. Food and Drug Administration (FDA) has set a date of September 13, 2023 for the meeting of the Cardiovascular and Renal Drugs Advisory Committee to review the supplemental New Drug Application for patisiran, an […]
New AI Tool Beats Standard Approaches for Detecting Heart Attacks
PITTSBURGH — A new machine learning model uses electrocardiogram (ECG) readings to diagnose and classify heart attacks faster and more accurately than current approaches, according to a study led by University of Pittsburgh researchers that published today in Nature Medicine. “When a patient comes into the hospital with chest pain, the first […]
PocDoc partners with NHS Targeted Lung Health Programme in North East, leveraging new biomarker Coronary Artery Calcium, to identify patients at increased risk of cardiovascular disease
CAMBRIDGE, England, June 29, 2023 /PRNewswire/ — PocDoc, the Cambridge-based digital health platform, today announces a major pilot with the NHS Targeted Lung Health Check programme in the North East, in partnership with cardiologist Dr Alan Bagnall and the NIHR Clinical Research Network North East and North Cumbria (CRN NENC). As documented widely in recent weeks, the NHS England Targeted […]
Recent
BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure
Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease
Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging
Popular
- No commented posts yet